| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
on Glucose Metabolism in Cultured Human Muscle Cells from Nondiabetic and Type 2 Diabetic Subjects1
Veterans Affairs Medical Center and Department of Medicine (0673), University of California-San Diego (T.P.G., L.C., S.M., R.R.H.), La Jolla, California 92093; and the Veterans Affairs Medical Center and Department of Medicine, University of Arkansas for Medical Sciences (P.A.K.), Little Rock, Arkansas 72205
Address all correspondence and requests for reprints to: Dr. Theodore P. Ciaraldi, Department of Medicine (0673), University of California-San Diego, La Jolla, California 92093. E-mail: tciaraldi{at}ucsd.edu
The effects of tumor necrosis factor-
(TNF
) on glucose uptake and
glycogen synthase (GS) activity were studied in human skeletal muscle
cell cultures from nondiabetic and type 2 diabetic subjects. In
nondiabetic muscle cells, acute (90-min) exposure to TNF
(5 ng/ml)
stimulated glucose uptake (73 ± 14% increase) to a greater
extent than insulin (37 ± 4%; P < 0.02).
The acute uptake response to TNF
in diabetic cells (51 ± 6%
increase) was also greater than that to insulin (31 ± 3%;
P < 0.05). Prolonged (24-h) exposure of
nondiabetic muscle cells to TNF
resulted in a further stimulation of
uptake (152 ± 31%; P < 0.05), whereas the
increase in cells from type 2 diabetics was not significant compared
with that in cells receiving acute treatment. After TNF
treatment,
the level of glucose transporter-1 protein was elevated in nondiabetic
(4.6-fold increase) and type 2 (1.7-fold) cells. Acute TNF
treatment
had no effect on the fractional velocity of GS in either nondiabetic or
type 2 cells. Prolonged exposure reduced the GS fractional velocity in
both nondiabetic and diabetic cells. In summary, both acute and
prolonged treatment with TNF
up-regulate glucose uptake activity in
cultured human muscle cells, but reduce GS activity. Increased skeletal
muscle glucose uptake in conditions of TNF
excess may serve as a
compensatory mechanism in the insulin resistance of type 2 diabetes.
This article has been cited by other articles:
![]() |
E. Polkinghorne, Q. Lau, G. J. Cooney, E. W. Kraegen, and M. E. Cleasby Local activation of the I{kappa}K-NF-{kappa}B pathway in muscle does not cause insulin resistance Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E316 - E325. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nieto-Vazquez, S. Fernandez-Veledo, C. de Alvaro, C. M. Rondinone, A. M. Valverde, and M. Lorenzo Protein-Tyrosine Phosphatase 1B-Deficient Myocytes Show Increased Insulin Sensitivity and Protection Against Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance Diabetes, February 1, 2007; 56(2): 404 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grohmann, E. Foulstone, G. Welsh, J. Holly, J. Shield, E. Crowne, and C. Stewart Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNF{alpha} J. Physiol., October 1, 2005; 568(1): 229 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Berggren, M. W. Hulver, and J. A. Houmard Fat as an endocrine organ: influence of exercise J Appl Physiol, August 1, 2005; 99(2): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Plomgaard, P. Keller, C. Keller, and B. K. Pedersen TNF-{alpha}, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue J Appl Physiol, June 1, 2005; 98(6): 2019 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Alvaro, T. Teruel, R. Hernandez, and M. Lorenzo Tumor Necrosis Factor {alpha} Produces Insulin Resistance in Skeletal Muscle by Activation of Inhibitor {kappa}B Kinase in a p38 MAPK-dependent Manner J. Biol. Chem., April 23, 2004; 279(17): 17070 - 17078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Green, J. M. Rumberger, C. A. Stuart, and M. S. Ruhoff Stimulation of Lipolysis by Tumor Necrosis Factor-{alpha} in 3T3-L1 Adipocytes Is Glucose Dependent: Implications for Long-Term Regulation of Lipolysis Diabetes, January 1, 2004; 53(1): 74 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Eisenberg and R. L. Bell The Impact of Bariatric Surgery on Severely Obese Patients With Diabetes Diabetes Spectr, October 1, 2003; 16(4): 240 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Ho, K. P. Davy, M. S. Hickey, S. A. Summers, and C. L. Melby Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E799 - E808. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Togashi, N. Ura, K. Higashiura, H. Murakami, and K. Shimamoto Effect of TNF-{alpha}-Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats Hypertension, February 1, 2002; 39(2): 578 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Halse, S. L. Pearson, J. G. McCormack, S. J. Yeaman, and R. Taylor Effects of Tumor Necrosis Factor-{alpha} on Insulin Action in Cultured Human Muscle Cells Diabetes, May 1, 2001; 50(5): 1102 - 1109. [Abstract] [Full Text] |
||||
![]() |
T. H. Elsasser, J. L. Sartin, A. Martínez, S. Kahl, L. Montuenga, R. Pío, R. Fayer, M. J. Miller, and F. Cuttitta Underlying Disease Stress Augments Plasma and Tissue Adrenomedullin (AM) Responses to Endotoxin: Colocalized Increases in AM and Inducible Nitric Oxide Synthase within Pancreatic Islets Endocrinology, November 1, 1999; 140(11): 5402 - 5411. [Abstract] [Full Text] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |